According to Nevro 's latest financial reports the company's total assets are $0.63 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.63 B | 5.53% |
2022-12-31 | $0.60 B | 4.85% |
2021-12-31 | $0.57 B | -27.22% |
2020-12-31 | $0.78 B | 68.09% |
2019-12-31 | $0.46 B | 1.41% |
2018-12-31 | $0.46 B | 2% |
2017-12-31 | $0.45 B | 5.45% |
2016-12-31 | $0.43 B | 47.87% |
2015-12-31 | $0.29 B | 43.8% |
2014-12-31 | $0.20 B | 168.52% |
2013-12-31 | $75.41 M | 53.55% |
2012-12-31 | $49.11 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $98.72 B | 15,429.96% | ๐บ๐ธ USA |
Abiomed ABMD | $1.69 B | 166.87% | ๐บ๐ธ USA |
Intuitive Surgical ISRG | $15.44 B | 2,329.00% | ๐บ๐ธ USA |
Orthofix Medical
OFIX | $0.92 B | 45.56% | ๐บ๐ธ USA |